ProCE Banner Activity

Continued Evolution of Immunotherapy-Based Treatment in NSCLC: Multidisciplinary Perspectives for Clinical Practice

Events

Share

Provided by

ProCE Banner

Supporters

Regeneron Pharmaceuticals, Inc